Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effect
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Histone deacetylase 9 promoter hypomethylation associated with adipocyte dysfunction is a statin-related metabolic effect ; volume:12 ; number:1 ; day:14 ; month:5 ; year:2020 ; pages:1-12 ; date:12.2020
Clinical epigenetics ; 12, Heft 1 (14.5.2020), 1-12, 12.2020
- Creator
-
Khamis, Amna
Boutry, Raphael
Canouil, Mickaël
Mathew, Sumi
Lobbens, Stephane
Crouch, Hutokshi
Andrew, Toby
Abderrahmani, Amar
Tamanini, Filippo
Froguel, Philippe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-020-00858-w
- URN
-
urn:nbn:de:101:1-2020071806132781501408
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khamis, Amna
- Boutry, Raphael
- Canouil, Mickaël
- Mathew, Sumi
- Lobbens, Stephane
- Crouch, Hutokshi
- Andrew, Toby
- Abderrahmani, Amar
- Tamanini, Filippo
- Froguel, Philippe
- SpringerLink (Online service)
Other Objects (12)
Histone deacetylase 6 in cancer
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
Histone deacetylase 6 in cancer
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro
Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
Histone deacetylase 6 in cancer
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Dendritic cell development requires histone deacetylase activity
Limited proteolysis of human histone deacetylase 1
Development of class IIa histone deacetylase inhibitors
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Nitric oxide affects histone acetylation by inhibiting histone deacetylase activity in Arabidopsis
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Nanomicelles potentiate histone deacetylase inhibitor efficacy in vitro